Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
News
All NewsCompaniesIndexesCurrency / ForexCommoditiesCryptocurrenciesETFInterest RatesEconomyThemesSectors 

ADRs End Lower; AstraZeneca, Can-Fite BioPharma Trade Actively

01/24/2023 | 05:48pm EST

By Denny Jacob


International stocks trading in New York closed lower on Tuesday.

The S&P/BNY Mellon index of American depositary receipts edged down 0.3% to 155.25. The European index ticked down 0.7% to 146.31. The Asian index moved down 0.1% to 187.51. The Latin American index gained 1.5% to 198.52, while the emerging-markets index was virtually unchanged at 317.05.

AstraZeneca PLC was among those whose ADRs traded actively. The pharmaceutical giant moved down 2% following a collaboration with Thermo Fisher Scientific Inc. to develop a solid tissue and blood-based companion diagnostic test for tagrisso, part of a multi-year agreement.

Can-Fite BioPharma Ltd. slipped 6.3% after the biotechnology company said it filed a patent application that covers the use of namodenoson for the treatment of pancreatic cancer after announcing the anti-cancer drug significantly inhibits the growth of pancreatic carcinoma as a stand-alone treatment.


Write to Denny Jacob at denny.jacob@wsj.com


(END) Dow Jones Newswires

01-24-23 1747ET

Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -0.21% 10622 Delayed Quote.-5.12%
CAN-FITE BIOPHARMA LTD. -8.16% 0.045 End-of-day quote.-46.43%
THERMO FISHER SCIENTIFIC -0.65% 573.63 Delayed Quote.4.84%
Latest news
05:57pU.S. lawmakers ask Kerry to urge UAE to replace oil boss as COP28 president
RE
05:51pIM Cannabis Provides Update to Listed Issuer Financing Exemption Offering
AQ
05:51pHelbiz Provides Transparency on Filed Proxy Statement
BU
05:48pNorth Korea slams United States for pledging tanks to Ukraine
RE
05:48pEU must answer U.S. clean energy subsidies, commissioner says on Washington visit
RE
05:47pFitch Upgrades Greece to BB+, Sees Headline Inflation Falling to 5% in 2023
DJ
05:46pTocvan Announces Private Placement with Strategic Investors
AQ
05:42pIsrael's Netanyahu visits scene of deadly Jerusalem shooting
RE
05:41pRecession fears pose challenge to energy shares after stellar year
RE
05:39pDaniel abed khalif remains in police custody and is due to appea…
RE
Latest news